Immune system cell activation

Immune system cell activation" is not a specific molecule or receptor but rather a broad biological process describing the transition of immune cells from a resting to an active state in response to stimuli such as pathogens, antigens, or cytokines. This process involves multiple molecular pathways and receptors—including antigen receptors (TCR on T cells and BCR on B cells), cytokine receptors, pattern recognition receptors like Toll-like receptors (TLRs), and co-stimulatory molecules—which together orchestrate the functional responses of both innate and adaptive immunity[1][2][4]. Key markers used to identify activated immune cells include surface proteins such as CD69 and CD25 for T cells[5]. Because "immune system cell activation" refers to a complex physiological event rather than a single targetable entity, it is not considered a canonical therapeutic target itself. Instead, drugs typically modulate specific molecules involved in this process—such as checkpoint inhibitors targeting PD1/PDL1 pathways in cancer immunotherapy—rather than "cell activation" per se. In summary, "Immune system cell activation" is too broad for use as a canonical drug target name; it encompasses many distinct molecular targets that mediate the initiation and regulation of immune responses.

Other names

Immune cell activationActivation of immune system cellsImmune activation